Company PT Phapros, Tbk

Company PT Phapros, Tbk

PEHA

ID1000147507

Pharmaceuticals

Equities

PEHA

ID1000147507

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Pharmaceuticals

End-of-day quote INDONESIA S.E. Other stock markets 03:30:00 26/04/2024 am IST			5-day change	1st Jan Change
496 ^IDR	0.00%		-0.80%	-22.50%

06/04	PT Phapros, Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	PT Phapros, Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

PT Phapros Tbk is an Indonesia-based pharmaceutical company. The Company's business pillars consist of branded/ethical prescription medicines: hospitals and pharmacies in addition to other healthcare institutions; over-the-counter drugs: pharmacies, retail; generic prescription drugs: government institutions and hospitals; toll-in manufacturing, and medical device. It offers medicines for cardiovascular and hematopoietic, gastrointestinal and hepatobiliary, hormone Genito, urinary endocrine and metabolic, vitamins and minerals nutrition, dermatology, local anesthesia, immune & allergy, and others. The Company's medical devices include ACS MB system, ACS FB and FB PS, Primary Hip Stem, INASHUNT Semilunar Flushing, BoneFill Ortho and NPC-STRIP G. Its branded drugs include Colkatriol 0.25 mcg 30 Cap, Diafac XR, Diafac 500 mg 10 tablets, Spirolactone 25 & 1, Dextamine Syrup 60 ml, Diapros Tablet, Proinfarction, anemone, Pladel, and others. The Company also operates calibration laboratory.

Number of employees: 1,474

IDR in Million	2022	Weight	2023	Weight	Delta
Generic Drugs Bearing 51.9 %	554,596	47.5 %	526,103	51.9 %	-5.14%
Ethical 28.3 %	372,689	31.9 %	286,632	28.3 %	-23.09%
Over The Counter 18.1 %	218,335	18.7 %	183,282	18.1 %	-16.05%
Toll-in 1.8 %	22,854	2.0 %	18,113	1.8 %	-20.74%

IDR in Million	2022	Weight	2023	Weight	Delta
Indonesia 100.0 %	1,168,474	100.0 %	1,014,130	100.0 %	-13.21%

Managers	Title	Age	Since
Hadi Kardoko CEO	Chief Executive Officer	47	01/20/01
David Sidjabat DFI	Director of Finance/CFO	-	27/21/27
Aries Badrus Sholeh CTO	Chief Tech/Sci/R&D Officer	-	-
Yudhi Arieffianto CTO	Chief Tech/Sci/R&D Officer	-	-
Santosa Adi Wibawa CTO	Chief Tech/Sci/R&D Officer	-	-
Maraja Jeson Siregar SAM	Sales & Marketing	-	08/23/08
Nurtjahjo Walujo Wibowo PRN	Corporate Officer/Principal	-	08/23/08
Bambang Priyanto PRN	Corporate Officer/Principal	-	01/01/01
Ida Rahmi Kurniasih PRN	Corporate Officer/Principal	-	-
Erfan Rio Prananto AUD	Comptroller/Controller/Auditor	-	-

Members of the board	Title	Age	Since
Masrizal Achmad Syarief BRD	Director/Board Member	68	01/08/01
Chrisma Aryani Albandjar BRD	Director/Board Member	51	27/21/27
Maxi Rein Rondonuwu CHM	Chairman	-	27/21/27
Bimo Wijayanto BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	840,000,000	0	0	13.88 %
Stock B	1	840,000,000	233,237,790 ( 27.77 %)	0

Name	Equities	%	Valuation
PT KIMIA FARMA TBK 56.77 %	476,901,860	56.77 %	16 M Rp
Masrizal Achmad Syarief 9.625 %	80,851,650	9.625 %	3 M Rp

PT Phapros Tbk

Menara Rajawali Jalan Dr. Ide Anak Agung Gde Agung

12950, Jakarta

http://www.phapros.co.id

	1st Jan change	Capi.
PT PHAPROS, TBK	-22.50%	25.68M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals